FR2333516A1 - Production de virus dans des cultures de tissus sans utiliser de serum - Google Patents
Production de virus dans des cultures de tissus sans utiliser de serumInfo
- Publication number
- FR2333516A1 FR2333516A1 FR7536749A FR7536749A FR2333516A1 FR 2333516 A1 FR2333516 A1 FR 2333516A1 FR 7536749 A FR7536749 A FR 7536749A FR 7536749 A FR7536749 A FR 7536749A FR 2333516 A1 FR2333516 A1 FR 2333516A1
- Authority
- FR
- France
- Prior art keywords
- mumps
- esp
- tissue culture
- prepn
- additives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18851—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7536749A FR2333516A1 (fr) | 1975-12-01 | 1975-12-01 | Production de virus dans des cultures de tissus sans utiliser de serum |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7536749A FR2333516A1 (fr) | 1975-12-01 | 1975-12-01 | Production de virus dans des cultures de tissus sans utiliser de serum |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2333516A1 true FR2333516A1 (fr) | 1977-07-01 |
FR2333516B1 FR2333516B1 (fr) | 1979-09-21 |
Family
ID=9163159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7536749A Granted FR2333516A1 (fr) | 1975-12-01 | 1975-12-01 | Production de virus dans des cultures de tissus sans utiliser de serum |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2333516A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0229485A2 (fr) * | 1986-01-09 | 1987-07-22 | Spectral Bioanalysis Ltd. | Milieu promoteur de croissance pour culture de cellules et procédé pour la culture de cellules utilisant ce milieu |
-
1975
- 1975-12-01 FR FR7536749A patent/FR2333516A1/fr active Granted
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS" * |
VOLUME 59, 9077C 1963 ) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0229485A2 (fr) * | 1986-01-09 | 1987-07-22 | Spectral Bioanalysis Ltd. | Milieu promoteur de croissance pour culture de cellules et procédé pour la culture de cellules utilisant ce milieu |
EP0229485A3 (fr) * | 1986-01-09 | 1989-02-22 | Spectral Bioanalysis Ltd. | Milieu promoteur de croissance pour culture de cellules et procédé pour la culture de cellules utilisant ce milieu |
Also Published As
Publication number | Publication date |
---|---|
FR2333516B1 (fr) | 1979-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bergmann et al. | Membrane insertion at the leading edge of motile fibroblasts. | |
CA2087525A1 (fr) | Immunotherapie adoptive au moyen de l'interleukine 7 | |
HK1019233A1 (en) | Animal cells and processes for the replication of influenza viruses | |
ES8202584A1 (es) | Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada. | |
AU554080B2 (en) | Production of viral antisens | |
Gardner | The use of tricine buffer in animal tissue cultures | |
ES8104405A1 (es) | Procedimiento para preparar una vacuna de virus de gripe | |
FR2333516A1 (fr) | Production de virus dans des cultures de tissus sans utiliser de serum | |
NL7514074A (en) | Protamine zinc insulin additives - to tissue culture media for prepn of viral vaccines esp mumps and german measles | |
IE47060B1 (en) | Process for the cultivation of viruses | |
FR2227276A1 (en) | Non-toxic nitrogen-active blood serum fractions - for culture of human diploid fibro-blasts, are prepd. by fractionation using ultrafiltration membrane sieves | |
CZ659090A3 (en) | Preparation for preparing antigens and process for preparing virus of early summer meningoencephalitis | |
GB1436323A (en) | Cell and virus culture systems | |
GB1015262A (en) | Virus culture | |
Maldarelli et al. | Increased yield of mouse mammary tumor virus (MMTV) by cultivation of monolayer-derived mammary tumor cells in suspension | |
PT72015B (en) | Process for preparing "invitro" cultures of hepatitis b virus | |
FR2261779A1 (en) | Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium | |
FR2244542A1 (en) | Vaccines prepd from IB-RS-2- cells - for treatment of porcine pests | |
GB1480690A (en) | Tissue culture media | |
NL7709998A (en) | Foetal canine lung diploid cell line - for virus cultures esp. for rabies vaccine prodn. | |
JPS55131387A (en) | Cultivation of cell | |
JPS5639795A (en) | Preparation of interferon | |
IT1201407B (it) | Procedimento di preparazione di un estratto antigenico totale batterico da usarsi per la produzione di vaccini | |
RO95356A2 (fr) | Procede d'obtetion d'un preparation pour milieux de culture | |
CA2250714A1 (fr) | Cellules animales et procedes de replication des virus de la grippe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |